Back to Hematology
Hematologyv2004Evidence-Based

Follicular Lymphoma International Prognostic Index (FLIPI)

Estimates overall survival in patients with follicular lymphoma based on 5 adverse prognostic factors to stratify patients into risk groups for treatment planning.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
flipi score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Follicular Lymphoma International Prognostic Index (FLIPI) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within hematology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of adverse prognostic factors (1 point each): Age >60 years + >4 nodal sites + Elevated LDH + Hemoglobin <120 g/L + Stage III-IV

Clinical Pearls & Practice Notes

  • FLIPI was developed from 4167 patients diagnosed between 1985-1992
  • Nodal sites refer to anatomical regions (e.g., cervical, axillary, inguinal, etc.)
  • Ann Arbor staging: Stage III involves lymph nodes on both sides of diaphragm; Stage IV involves extralymphatic organs
  • LDH elevation is defined as above the upper limit of normal for the testing laboratory
  • FLIPI-2 exists with different parameters but original FLIPI remains widely used
  • Mnemonic 'NoLaSH': Nodal areas, LDH, Age, Stage, Hemoglobin

Evidence & Literature Citations

  1. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004 Sep 1;104(5):1258-65.
  2. van de Schans SA, Steyerberg EW, Nijziel MR, Creemers GJ, Janssen-Heijnen ML, van Spronsen DJ. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting. Ann Oncol. 2009 Oct;20(10):1697-702.
  3. Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009 Sep 20;27(27):4555-62.

Score Interpretation Ranges

Low Risk0 – 1 pts

0-1 adverse factors

Intermediate Risk2 – 2 pts

2 adverse factors

High Risk3 – 5 pts

3-5 adverse factors

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.